Scott Hutton - 17 Nov 2021 Form 4 Insider Report for BIODESIX INC (BDSX)

Role: President & CEO, Director
Signature: /s/ Robin H. Cowie as Attorney-in-Fact for Scott Hutton
Issuer symbol: BDSX
Transactions as of: 17 Nov 2021
Net transactions value: +$19,375
Form type: 4
Filing time: 18 Nov 2021, 16:46:35 UTC
Previous filing: 14 Mar 2022
Next filing: 10 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BDSX	Common Stock	Purchase	$19,375	+3,000	+44%	$6.46	9,762	17 Nov 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares of Common Stock were purchased in multiple transactions at prices ranging from $6.23 to $6.57, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
F2	Includes 1,262 shares acquired under the BDSX stock purchase plan on August 31, 2021.

Content

The price reported in Column 4 is a weighted average price. These shares of Common Stock were purchased in multiple transactions at prices ranging from $6.23 to $6.57, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.

Includes 1,262 shares acquired under the BDSX stock purchase plan on August 31, 2021.